The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Vertigon 16 mg tablets

16 milligram(s) Tablet

Aurobindo Pharma (Malta) LimitedPA1445/023/002

Main Information

Trade NameVertigon 16 mg tablets
Active SubstancesBetahistine dihydrochloride
Strength16 milligram(s)
Dosage FormTablet
Licence HolderAurobindo Pharma (Malta) Limited
Licence NumberPA1445/023/002

Group Information

ATC CodeN07CA Antivertigo preparations
N07CA01 betahistine


Licence Issued03/10/2014
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable ListBetahistine 16mg Tablets
Interchangeable List CodeIC0084-038-002
Interchangeable List DocumentPDF of Interchangeable List
« Back